StonvexLoading…
StonvexStonvexStonvexCore line items from NU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $11.52B | $8.03B | $4.79B | $1.70B |
Operating Income | $2.80B | $1.54B | $-308.90M | $-170.16M |
Net Income | $1.97B | $1.03B | $-364.63M | $-165.33M |
EPS (Diluted) | $0.40 | $0.21 | $-0.08 | $-0.10 |
Total Assets | $49.93B | $43.35B | $29.93B | $19.86B |
Total Liabilities | $42.28B | $36.94B | $25.04B | $15.42B |
Cash & Equivalents | $9.19B | $5.92B | $4.17B | $2.71B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |